Lovastatin
Lovastatin is a pharmaceutical drug with 39 clinical trials. Currently 2 active trials ongoing. Historical success rate of 73.3%.
Success Metrics
Based on 22 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
23
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
22 of 33 finished
33.3%
11 ended early
2
trials recruiting
39
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
Interventions for Reading Disabilities in NF1
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Synaptic Plasticity and Cognitive Function in RASopathies
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Clinical Trials (39)
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
Interventions for Reading Disabilities in NF1
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Synaptic Plasticity and Cognitive Function in RASopathies
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis
Neurophysiological and Acute Pharmacological Studies in FXS Patients
Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Lovastatin for Treatment of Brain Arteriovenous Malformations
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Pharmacological Treatment of Rett Syndrome With Statins
Pre-Prostatectomy Lovastatin on Prostate Cancer
A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease
Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 39